Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:10 Issue:1 Number:22 ISSN#:2563-5476
RCT
ACE Report #12942
Ace Report Cover Shoulder & Elbow

Dextrose Prolotherapy Improved Pain & Function in LE Patients Compared to HA at 12 Weeks


How to Cite

OrthoEvidence. Dextrose Prolotherapy Improved Pain & Function in LE Patients Compared to HA at 12 Weeks. ACE Report. 2021;10(1):22. Available from: https://myorthoevidene.com/AceReport/Report/12942

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Injection Therapy in Patients with Lateral Epicondylalgia: Hyaluronic Acid or Dextrose Prolotherapy? A Single-Blind, Randomized Clinical Trial.

J Altern Complement Med . 2020 Dec;26(12):1169-1175

Contributing Authors: H Apaydin Z Bazancir Z Altay

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Thirty-two patients with chronic lateral epicondylalgia (LE) were randomized to receive an injection with single dose pf high-molecular-weight hyaluronic acid (HA) or 3 doses of dextrose prolotherapy (DPT). The primary outcomes of interest included pain at rest, during movement, and at night on a Visual Analogue Scale (VAS), and physical function evaluated with the Quick-Disabilities of the Arm, S...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE